Ireland
--:--IST
Recruiting Not applicable

Bone Evaluation by Ultrasound Radiofrequency Echographic Multi Spectrometry (REMS) vs Dual X-ray Absorptiometry (DXA)

NCT06371755 · tracked via the Priya Life Science Italy tracker
Sponsor
Paola Pisani
Phase
Not applicable
Started
2019-11-19
Last updated
2025-09-05

Condition(s) studied

Osteoporosis Diagnosis

Investigational drug(s) / intervention(s)

Ultrasound examination with REMS technology

Ultrasound examination with REMS technology: The proposed study is defined as interventional because it introduces an ultrasound examination in the standard clinical routine. The diagnostic approach does not vary during the study and the prescription of any therapeutic treatment is performed on the basis of the conventional DXA diagnosis. This ultrasound examination does not involve additional risks for the patient with the benefit of not using ionizing radiation; it lasts only few minutes and can be performed without moving the patient from the same bed on which he is already positioned for DXA examination.

Study summary

Bone Density Evaluation by means of the Ultrasound Technology Named Radiofrequency Echographic Multi Spectrometry (REMS) in Comparison With DXA Technique.

Clinical Center involved in the study:IRCCS Orthopedic institute Galeazzi - Sant'Ambrogio The clinical study will evaluate the intra- and inter-operator repeatability of the REMS,(Radiofrequency Echographic Multi Spectrometry) ultrasound diagnostic technology implemented in the EchoStation device (Echolight Spa, Lecce) and the diagnostic accuracy in comparison with DXA (used as standard reference).

Eligibility

Sex
FEMALE
Min age
30 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * patients scheduled for lumbar and/or femoral DXA examination, * female sex, * age range 30-80 years (for repeatability study), age range 50-70 years (for accuracy study), * absence of severe obesity (BMI \< 40 kg/m2), * absence of severe walking difficulties, * cognitive underwriting of informed consent. Exclusion Criteria: * Male sex, * severe walking difficulties, * age below 30 years or over 80 years, * severe obesity (BMI \> 40 kg/m2), * declared pregnancy.

Primary outcome measure(s)

  • 1. REMS Technology intra - and inter-operator repeatability Evaluation. — up to 3 months
    The Root Mean Square - Coefficient of Variation (CV-RMS) parameter has been measured in order to calculate REMS intra- and inter-operator repeatability.

Trial sites (1)

FacilityCityRegionStatus
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Milan MI Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06371755 on ClinicalTrials.gov ↗ ← All trials in Italy